# GenSight Biologics funding rounds and investors

As of 21 Nov 2026, GenSight Biologics has raised $46.3M across 3 verified rounds on record (amounts in other currencies converted to USD), plus 1 round still being checked; latest: EUR 1,100,000.19 fundraising round, announced 19 Nov 2026.

A biopharma company focused on developing and commercializing innovative gene therapies

Website: https://www.gensight-biologics.com/  
Headquarters: Paris, France  
Page: https://fireround.dev/companies/gensight-biologics

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-19 | Fundraising | EUR 1,100,000.19 | not stated | Heights Capital, Invus | [businesswire.com](https://www.businesswire.com/news/home/20261119658009/en/GenSight-Biologics-Announces-Successful-EUR-1.1-Million-Fundraising-Supported-by-Existing-Shareholders), [google.com](https://www.google.com/goto?url=CAEScgHEIkXX1wj7gCef8ilt9QQVoYazMFef7zEaoZj1tMFQKyJAhmRDsSJazmxT2tsi3uWjePMr6WucG9WENusFNo8VXkp9HYcWXs89utzV8wWZi_zV0ZWe3NYvg_udtxv60VuzqzXxcT7py2DA6od2mduJpQ&gsessionid=EP2HT3VBEKa0Bf_TKi7YnCNqtuTGZdOS7htAn1h8-xVVcDOlFvUxUg), [google.com](https://www.google.com/goto?url=CAEScgHEIkXXJmyPBWm54aEqaXXxkKrWbGexMpFRu-OjFIt8JmN6ykGKQfXMdFaKhMIGc3BlRyOBoWCoZB0P50NcqVtdliLgped1LXx1JT6SywpOZo6WZmKa4s1aubZkpR_7D-ZI6dVMgTV2Gw6A5dDI6imNKA&gsessionid=v22o56NV_M4wUHBZIm0gyVG2C4guLB0TbBTfxPcFFTwG8m7KMjkGDA) |
| 2025-12-29 | Fundraising | EUR 2,894,715.96 | not stated | Alumni Ventures, Heights Capital, Invus | [businesswire.com](https://www.businesswire.com/news/home/20251228281353/en/GenSight-Biologics-Announces-Successful-Fundraising-Amounting-to-Nearly-%E2%82%AC2.9-Million) |
| 2013-04-08 | Series A | €32m | Abingworth, Index Ventures, Novartis, Versant Ventures | none named | [prnewswire.com](https://www.prnewswire.com/news-releases/gensight-biologics-raises-32m-in-a-series-a-financing-for-ophthalmic-gene-therapy-201880791.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.
